November 27, 2017 08:00 ET
TORONTO, ON–(Marketwired – November 27, 2017) – In an upcoming webinar hosted by Xtalks on Tuesday, December 5, 2017, guest speakers from Simbec-Orion Group and Orion Clinical Oncology Advisory Board will discuss strategic considerations for the molecule, including a brief review of the dynamic research landscape of oncology drug development, patient recruitment and product development aspects.
Key topics include:
- What is on the horizon in oncology drug development
- Clinical development strategy and tactics
- Early V late phase
- Regulatory considerations
- Trial design and protocol development phase
- Case studies
To learn more information about this complimentary event visit: Conducting Early Phase Oncology Studies, Successfully Moving Through to Proof of Concept.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
You are using an outdated browser
For a better experience using this site, please upgrade to a modern web browser.
Powered by WPeMatico